These genes include well annotated tumor-suppressor genes and oncogenes (e.g., TGFBR2 and MYC as well as genes that have never been previously linked to cancer in general, or to increased BC risk (including ADCY3, ATXN7, CFL1 and LPAR2). This evidence concerns the gene TGFBR2 and cancer.